Due Diligence at its finest
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$WTCG - Patent License Agreement grants to W Technologies a license for use of the patents owned by Smokefree Innotec for marketing of the Smokefree products http://finance.yahoo.com/news/w-technologies-inc-enters-patent-180208936.html?soc_src=mediacontentstory
$WTCG - Patent License Agreement grants to W Technologies a license for use of the patents owned by Smokefree Innotec for marketing of the Smokefree products http://finance.yahoo.com/news/w-technologies-inc-enters-patent-180208936.html?soc_src=mediacontentstory
$PPCH - Propanc intends to progress their lead product along the rigorous, formal non-clinical and clinical development pathway required to obtain regulatory approval to market its proenzyme formulation. http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - Propanc intends to progress their lead product along the rigorous, formal non-clinical and clinical development pathway required to obtain regulatory approval to market its proenzyme formulation. http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - Propanc's leading products are novel, patented formulations based on proenzymes, which are inactive precursors of enzymes. As a result of positive early indications of the anti-cancer effects http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - Propanc's leading products are novel, patented formulations based on proenzymes, which are inactive precursors of enzymes. As a result of positive early indications of the anti-cancer effects http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - aims to fast-track development of proenzyme-related oncology products into clinical trials, initially for colorectal and pancreatic tumors. The world market for colorectal cancer is expected to reach $8.8 billion by 2020 and the global pancreatic cancer market is projected to exceed $1.2 billion by the year 2015, according to Global Analyst Reports http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - aims to fast-track development of proenzyme-related oncology products into clinical trials, initially for colorectal and pancreatic tumors. The world market for colorectal cancer is expected to reach $8.8 billion by 2020 and the global pancreatic cancer market is projected to exceed $1.2 billion by the year 2015, according to Global Analyst Reports http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - Dr Kenyon, Chief Scientific Officer of Propanc Health Group, states, "After a detailed strategic review of our scientific and preclinical research, our development team determined I.V. injection as the preferred route of administration. This approach would be the best way to maximise results in future patient trials, by ensuring maximum exposure of the drug to the tumor site." http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - Dr Kenyon, Chief Scientific Officer of Propanc Health Group, states, "After a detailed strategic review of our scientific and preclinical research, our development team determined I.V. injection as the preferred route of administration. This approach would be the best way to maximise results in future patient trials, by ensuring maximum exposure of the drug to the tumor site." http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$WTCG - launched a new website, http://www.PotEstate.com, to feature its niche-real estate services. The website and business model are a joint effort of W Technologies' wholly owned real estate subsidiary and its joint venture partner, Total Growing Solutions, Inc., specializing in finding real estate and providing full-service consulting to those in the medical marijuana and pot dispensary business http://finance.yahoo.com/news/w-technologies-inc-launches-potestate-123000584.html?soc_src=mediacontentstory
$WTCG - launched a new website, http://www.PotEstate.com, to feature its niche-real estate services. The website and business model are a joint effort of W Technologies' wholly owned real estate subsidiary and its joint venture partner, Total Growing Solutions, Inc., specializing in finding real estate and providing full-service consulting to those in the medical marijuana and pot dispensary business http://finance.yahoo.com/news/w-technologies-inc-launches-potestate-123000584.html?soc_src=mediacontentstory
$WTCG - Moving forward from Pinks to OTCQB http://www.stockwatch.com/News/Item.aspx?bid=U-i1118595-U%3aWTCG-20140527&symbol=WTCG®ion=U
$WTCG - Moving forward from Pinks to OTCQB http://www.stockwatch.com/News/Item.aspx?bid=U-i1118595-U%3aWTCG-20140527&symbol=WTCG®ion=U
$WTCG - when approved by the SEC, will reinstate the Company as a fully-reporting Company and eligible to be quoted on the OTCQB http://www.stockwatch.com/News/Item.aspx?bid=U-i1118595-U%3aWTCG-20140527&symbol=WTCG®ion=U
$WTCG - when approved by the SEC, will reinstate the Company as a fully-reporting Company and eligible to be quoted on the OTCQB http://www.stockwatch.com/News/Item.aspx?bid=U-i1118595-U%3aWTCG-20140527&symbol=WTCG®ion=U
$WTCG - pre-mkt News!!! - to Register Its Common Stock With the SEC in Order to Become a Fully-Reporting Company 5/27/14 http://www.stockwatch.com/News/Item.aspx?bid=U-i1118595-U%3aWTCG-20140527&symbol=WTCG®ion=U
$WTCG - pre-mkt News!!! - to Register Its Common Stock With the SEC in Order to Become a Fully-Reporting Company 5/27/14 http://www.stockwatch.com/News/Item.aspx?bid=U-i1118595-U%3aWTCG-20140527&symbol=WTCG®ion=U
$PPCH - is now refocusing the preferred route of administration to intravenous (I.V.) injection http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - is now refocusing the preferred route of administration to intravenous (I.V.) injection http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - Targets Cancer Patient Trials in 2015 http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - Targets Cancer Patient Trials in 2015 http://finance.yahoo.com/news/propanc-health-group-targets-cancer-200000739.html?soc_src=mediacontentstory
$PPCH - is in the process of responding to inquiries made by examiners from these two important jurisdictions, with a view toward securing a grant of patent in each region covering as many aspects of its technology as possible http://www.stockwatch.com/News/Item.aspx?bid=U-z10083040-U%3aPPCH-20140523&symbol=PPCH®ion=U
$PPCH - is in the process of responding to inquiries made by examiners from these two important jurisdictions, with a view toward securing a grant of patent in each region covering as many aspects of its technology as possible http://www.stockwatch.com/News/Item.aspx?bid=U-z10083040-U%3aPPCH-20140523&symbol=PPCH®ion=U
$PPCH - a/h News Fri - Propanc Makes Substantial Progress With Lead Patent Application for New Cancer Treatment in Key Global Regions http://www.stockwatch.com/News/Item.aspx?bid=U-z10083040-U%3aPPCH-20140523&symbol=PPCH®ion=U
$PPCH - a/h News Fri - Propanc Makes Substantial Progress With Lead Patent Application for New Cancer Treatment in Key Global Regions http://www.stockwatch.com/News/Item.aspx?bid=U-z10083040-U%3aPPCH-20140523&symbol=PPCH®ion=U
$WTCG Shares Outstanding 49,333,070 a/o Apr 09, 2014
Float 12,275,954 a/o Apr 09, 2014
Authorized Shares 750,000,000 a/o Nov 20, 2013
http://www.otcmarkets.com/stock/WTCG/company-info
$WTCG Shares Outstanding 49,333,070 a/o Apr 09, 2014
Float 12,275,954 a/o Apr 09, 2014
Authorized Shares 750,000,000 a/o Nov 20, 2013
http://www.otcmarkets.com/stock/WTCG/company-info
$WTCG - Video Search underway for available real estate for medical marijuana
$WTCG - Video Search underway for available real estate for medical marijuana
$WTCG Video - Top 10 Future Technology That Exist Today
$WTCG Video - Top 10 Future Technology That Exist Today
$PPCH Propanc Makes Substantial Progress With Lead Patent Application for New Cancer Treatment in Key Global Regions http://www.stockwatch.com/News/Item.aspx?bid=U-z10083040-U%3aPPCH-20140523&symbol=PPCH®ion=U
$PPCH A/H NEWS!! Propanc Makes Substantial Progress With Lead Patent Application for New Cancer Treatment in Key Global Regions http://www.stockwatch.com/News/Item.aspx?bid=U-z10083040-U%3aPPCH-20140523&symbol=PPCH®ion=U
$AHII - secured shelf space in a number of 7-Eleven stores across Florida. Using the sales data from this initial 7-Eleven foothold, company CEO Anthony Sarvucci states the company will be able to prove that "that it is not only profitable to carry our American Heritage brand of premium disposable e-cigs, but to also prove that a high sell-through rate at the retail level can be achieved." http://www.benzinga.com/14/04/4481506/american-heritage-international-a-strong-competitor-in-a-high-growth-industry#ixzz31bJwMGXX
$AHII - secured shelf space in a number of 7-Eleven stores across Florida. Using the sales data from this initial 7-Eleven foothold, company CEO Anthony Sarvucci states the company will be able to prove that "that it is not only profitable to carry our American Heritage brand of premium disposable e-cigs, but to also prove that a high sell-through rate at the retail level can be achieved." http://www.benzinga.com/14/04/4481506/american-heritage-international-a-strong-competitor-in-a-high-growth-industry#ixzz31bJwMGXX
CBIS -"Cannabis Science has made solid progress so far this year. I am proud to be a part of this team and I am very positive about our future," stated Robert Kane, CFO of Cannabis Science. http://www.stockwatch.com/News/Item.aspx?bid=U-prLA33628-U%3aCBIS-20140522&symbol=CBIS®ion=U
CBIS -"Cannabis Science has made solid progress so far this year. I am proud to be a part of this team and I am very positive about our future," stated Robert Kane, CFO of Cannabis Science. http://www.stockwatch.com/News/Item.aspx?bid=U-prLA33628-U%3aCBIS-20140522&symbol=CBIS®ion=U
$CBIS - Cannabis Science - To support its existing CBN patent, the company has delivered pure CBN compound to two research facilities in Europe where testing will be started to establish activity of CBN alone and in combination with other cannabinoids in anxiety, sleep disorders as well as in variety of neurological conditions including Alzheimer's disease.
http://www.stockwatch.com/News/Item.aspx?bid=U-prLA33628-U%3aCBIS-20140522&symbol=CBIS®ion=U
$CBIS - Cannabis Science - To support its existing CBN patent, the company has delivered pure CBN compound to two research facilities in Europe where testing will be started to establish activity of CBN alone and in combination with other cannabinoids in anxiety, sleep disorders as well as in variety of neurological conditions including Alzheimer's disease.
http://www.stockwatch.com/News/Item.aspx?bid=U-prLA33628-U%3aCBIS-20140522&symbol=CBIS®ion=U